查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631196

幽門螺旋桿菌診斷市場分析報告：按類型、技術、最終用途、地區和細分市場預測，2025-2030 年

Helicobacter Pylori Diagnostics Market Analysis Report By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End Use, By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

幽門螺旋桿菌診斷市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球幽門螺旋桿菌診斷市場規模預計到2030年將達到9.6619億美元，2025年至2030年期間的複合年成長率為5.87%。個人化抗生素治療需求的增加和成本效益的提高預計將推動幽門螺旋桿菌 (H. pylori) 感染診斷的成長。

抗生素的易得性和可負擔性，以及較短的治療時間，推動了抗生素的採用以及對治療前後監測測試的需求。此外，幽門螺旋桿菌病菌感染上升、早期診斷的需求以及診斷技術的快速進步等因素將推動市場成長。然而，由於競爭激烈的環境而導致的維持價格的經濟壓力不斷增加，可能會阻礙幽門螺旋桿菌診斷市場的成長。

幽門螺旋桿菌是一種需氧革蘭氏陰性細菌，常見於胃。雖然它有利於維持平衡的胃生態系統，但它可能會導致胃黏膜感染。這種細菌可能是胃癌、十二指腸潰瘍、胃炎和胃潰瘍以及小腸感染疾病的病原體之一。因此，對能夠早期檢測病菌感染的幽門螺旋桿菌診斷藥物的需求日益增加。如果確診為幽門螺旋桿菌潰瘍，患者將接受 10 至 14 天的抗生素治療。幽門螺旋桿菌的治療包括甲硝唑、阿莫西林、克拉黴素和四環黴素等抗生素的組合，以及質子幫浦抑制劑、雷尼替丁檸檬酸鉍和次水楊酸鉍的組合。

免疫測量技術部門在 2018 年佔據了最大的市場佔有率，預計在預測期內將實現最快的複合年成長率。根據最終用戶，醫院部門在 2018 年佔據了最大的市場佔有率，而診斷實驗室預計在未來幾年以最快的複合年成長率擴張。按地區分類，北美引領全球幽門螺旋桿菌診斷市場。另一方面，預計亞太地區在 2019 年至 2026 年期間的複合年成長率最快。

幽門螺旋桿菌診斷市場報告重點

  • 免疫測定技術將在 2024 年佔據最大的市場佔有率，預計在預測期內將以最快的複合年成長率成長。
  • 在終端用戶中，醫院部門預計將在 2024 年佔據最大的市場佔有率，而診斷實驗室部門預計將在 2025 年至 2030 年間呈現最快的複合年成長率。
  • 由於醫療保健領域的重要性日益增加、感染疾病流行的增加以及人們意識的不斷增強，預計預測期內拉丁美洲的複合年成長率將達到 6.4%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
  • 市場限制因素分析
  • 商業環境分析
    • 依因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 波特五力分析

第4章 類型業務分析

  • 幽門螺旋桿菌診斷市場：類型變異分析
  • 裝置
    • 2018-2030 年裝備市場
  • 試劑
    • 2018-2030 年試劑市場
  • 服務
    • 服務市場，2018-2030

第5章 技術業務分析

  • 幽門螺旋桿菌診斷市場：技術變遷分析
  • 免疫測定
    • 免疫測定市場，2018 - 2030
  • POC
    • POC 市場，2018-2030
  • 分子診斷
    • 分子診斷市場，2018 - 2030

第6章 最終用途業務分析

  • 幽門螺旋桿菌診斷市場：最終用途變異分析
  • 醫院
    • 醫院市場，2018-2030
  • 診斷實驗室
    • 診斷實驗室市場，2018-2030
  • 診所
    • 診所市場，2018-2030

第7章 區域經營分析

  • 2024 年及 2030 年幽門螺旋桿菌診斷市場佔有率（按地區）
  • 北美洲
    • 2018 至 2030 年北美幽門螺旋桿菌診斷市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018 至 2030 年歐洲幽門螺旋桿菌診斷市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018 年至 2030 年亞太地區幽門螺旋桿菌診斷市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲幽門螺旋桿菌診斷市場，2018-2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲幽門螺旋桿菌診斷市場，2018-2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司分類
  • 戰略地圖
  • 2024 年公司市場佔有率分析
  • 公司簡介/上市公司
    • Biohit Oyj
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Meridian Bioscience
    • Bio-Rad Laboratories
    • Alpha Laboratories Ltd
    • Coris BioConcept
    • F. Hoffmann-La Roche AG
    • Certest BIoTec
    • Epitope Diagnostics, Inc.
Product Code: GVR-3-68038-699-8

Helicobacter Pylori Diagnostics Market Growth & Trends:

The global helicobacter pylori diagnostics market size is anticipated to reach USD 966.19 million by 2030, expanding at a CAGR of 5.87% from 2025 to 2030, according to a new report by Grand View Research. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.

Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.

H. pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.

The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.

Helicobacter Pylori Diagnostics Market Report Highlights:

  • Immunoassays technology held the largest market share in 2024 and is expected to witness the fastest CAGR over the forecast period
  • Among end user, hospital segment held the largest market share in 2024, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2025 to 2030
  • Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Helicobacter Pylori Diagnostics Market: Type Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
  • 5.2. Immunoassays
    • 5.2.1. Immunoassays Market, 2018 - 2030 (USD Million)
  • 5.3. POC
    • 5.3.1. POC Market, 2018 - 2030 (USD Million)
  • 5.4. Molecular Diagnostics
    • 5.4.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 6. End use Business Analysis

  • 6.1. Helicobacter Pylori Diagnostics Market: End use Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.3. Diagnostics Laboratories
    • 6.3.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 6.4. Clinics
    • 6.4.1. Clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Helicobacter Pylori Diagnostics Market Share By Region, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Mexico Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Argentina Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Biohit Oyj
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Collection Site Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Collection Site Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Quest Diagnostics Incorporated
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Collection Site Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Meridian Bioscience
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Collection Site Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Collection Site Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Alpha Laboratories Ltd
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Collection Site Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Coris BioConcept
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Collection Site Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. F. Hoffmann-La Roche AG
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Collection Site Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Certest Biotec
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Collection Site Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Epitope Diagnostics, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Collection Site Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 6 Global Helicobacter Pylori Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Mexico Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 Mexico Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 17 Canada Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 20 Europe Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 24 Germany Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 27 UK Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 UK Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 30 France Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 France Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 France Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 33 Italy Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Italy Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 36 Spain Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 Spain Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Denmark Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 45 Norway Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Norway Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 52 China Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 55 Japan Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 Japan Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Japan Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 58 India Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 India Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 India Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 South Korea Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 South Korea Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 64 Australia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 Australia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Australia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Thailand Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Latin America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Brazil Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 90 UAE Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Helicobacter Pylori Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Helicobacter Pylori Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Helicobacter Pylori Diagnostics Market: for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Helicobacter Pylori Diagnostics Market: for Reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global Helicobacter Pylori Diagnostics Market: for Services, 2018 - 2030 (USD Million)
  • Fig. 19 Global Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
  • Fig. 20 Global Helicobacter Pylori Diagnostics Market: for Immunoassays, 2018 - 2030 (USD Million)
  • Fig. 21 Global Helicobacter Pylori Diagnostics Market: for POC, 2018 - 2030 (USD Million)
  • Fig. 22 Global Helicobacter Pylori Diagnostics Market: for Molecular Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 23 Global Helicobacter Pylori Diagnostics Market: End use Movement Analysis
  • Fig. 24 Global Helicobacter Pylori Diagnostics Market: for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 25 Global Helicobacter Pylori Diagnostics Market: for Diagnostics Laboratories, 2018 - 2030 (USD Million)
  • Fig. 26 Global Helicobacter Pylori Diagnostics Market: for Clinics, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional Outlook, 2024 & 2030
  • Fig. 29 Global Helicobacter Pylori Diagnostics Market: Region Movement Analysis
  • Fig. 30 North America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 32 Canada Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 34 Europe Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 35 Germany Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 36 UK Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 37 France Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 38 Italy Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 39 Spain Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 42 Norway Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 44 Japan Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 45 China Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 46 India Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 47 Australia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 56 UAE Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)